Using Best–Worst Scaling to Measure Caregiver Preferences for Managing their Child’s ADHD: A Pilot Study

BackgroundManagement of attention-deficit/hyperactivity disorder (ADHD) is a trade-off between caregivers’ concerns about the benefits versus the risks of evidence-based treatment. Few studies have used choice-based methods to assess what treatment attributes matter most to caregivers.ObjectiveThe aim was to develop and to pilot an instrument to elicit caregivers’ preferences for evidence-based management of their child’s ADHD.MethodsMixed methods were used to develop a Best–Worst Scaling (BWS) instrument, and quantitative methods were used to pilot the instrument. Primary caregivers of children with ADHD from two community organizations were recruited for the development (n = 21) and pilot (n = 37) phase. The instrument was a BWS case 2, where 18 management profiles are presented one at a time, with respondents indicating the one best and one worst feature of each profile. Profiles were developed using a main effects orthogonal array. The mean of best-minus-worse scores was estimated, and attribute importance was based on the sum of maximum minus minimum scores for each attribute. Feasibility of eliciting stated preferences was evaluated with t tests and 95 % confidence intervals.ResultsSeven attributes (medication, therapy, school, caregiver training, provider specialty, provider communication, and out-of-pocket costs) with three levels each were identified. All mean scores were significant except for pediatrician management of the child’s ADHD (p = 0.089). Caregiver training had the highest relative importance, followed by medication and provider communication.ConclusionsThe BWS instrument was a relatively simple measure, caregivers completed it independently, and it distinguished the relative importance of different attributes in managing a child’s ADHD.

[1]  P. Lipkin,et al.  Attitudes About Stimulant Medication for Attention-Deficit/Hyperactivity Disorder Among African American Families in an Inner City Community , 2006, The Journal of Behavioral Health Services & Research.

[2]  L. Greenhill,et al.  Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults , 2002 .

[3]  W. Bilker,et al.  Cardiovascular Events and Death in Children Exposed and Unexposed to ADHD Agents , 2011, Pediatrics.

[4]  M. Olfson,et al.  National trends in the treatment of attention deficit hyperactivity disorder. , 2003, The American journal of psychiatry.

[5]  A. Winterstein Cardiovascular Safety of Stimulants in Children: Findings from Recent Population-Based Cohort Studies , 2013, Current Psychiatry Reports.

[6]  K. Soeken,et al.  Parental Perceptions and Satisfaction with Stimulant Medication for Attention‐Deficit Hyperactivity Disorder , 2003, Journal of developmental and behavioral pediatrics : JDBP.

[7]  M. Nübling,et al.  Analysis of Patients’ Preferences , 2010, The patient.

[8]  L. Magder,et al.  Psychotropic practice patterns for youth: a 10-year perspective. , 2003, Archives of pediatrics & adolescent medicine.

[9]  Steven G. Gilmour,et al.  Some new three-level orthogonal main effects plans robust to model uncertainty , 2004 .

[10]  L. Matza,et al.  Health State Utilities for Childhood Attention-Deficit/Hyperactivity Disorder Based on Parent Preferences in the United Kingdom , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

[11]  L. Magder,et al.  Psychotropic practice patterns for youth. , 2003 .

[12]  W. Pelham,et al.  A Discrete Choice Conjoint Experiment to Evaluate Parent Preferences for Treatment of Young, Medication Naive Children with ADHD , 2011, Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53.

[13]  W. Pelham,et al.  Enhancements to the Behavioral Parent Training Paradigm for Families of Children with ADHD: Review and Future Directions , 2004, Clinical child and family psychology review.

[14]  L. Palinkas,et al.  Investigating ADHD Treatment Trajectories: Listening to Families' Stories About Medication Use , 2007, Journal of developmental and behavioral pediatrics : JDBP.

[15]  M. Weissman,et al.  National trends in the use of psychotropic medications by children. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

[16]  S. Speedie,et al.  Prevalence variations in psychotropic treatment of children. , 1998, Journal of child and adolescent psychopharmacology.

[17]  R. Perou,et al.  Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007. , 2010, MMWR. Morbidity and mortality weekly report.

[18]  T. Flynn Valuing citizen and patient preferences in health: recent developments in three types of best–worst scaling , 2010, Expert review of pharmacoeconomics & outcomes research.

[19]  Subcommittee on Attention-Deficit,et al.  Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. , 2001, Pediatrics.

[20]  S. Pliszka,et al.  Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[21]  M. Nübling,et al.  Preferences for treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): a discrete choice experiment , 2009, BMC health services research.

[22]  Alexander G Fiks,et al.  Parental Preferences and Goals Regarding ADHD Treatment , 2013, Pediatrics.

[23]  Danielle L. Fettes,et al.  Public knowledge, beliefs, and treatment preferences concerning attention-deficit hyperactivity disorder. , 2007, Psychiatric services.

[24]  D. Lavallee,et al.  Continuous patient engagement in comparative effectiveness research. , 2012, JAMA.

[25]  Joanna Coast,et al.  Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations. , 2012, Health economics.

[26]  Ruel Jm,et al.  Are too many children being treated with methylphenidate , 1992 .

[27]  E. Hansen,et al.  Caught in a Balancing Act: Parents’ Dilemmas Regarding Their ADHD Child’s Treatment With Stimulant Medication , 2006, Qualitative health research.

[28]  T. Flynn,et al.  USING BEST-WORST SCALING IN HORIZON SCANNING FOR HEPATOCELLULAR CARCINOMA TECHNOLOGIES , 2012, International Journal of Technology Assessment in Health Care.

[29]  A. Riley,et al.  The meaning of attention-deficit/hyperactivity disorder medication and parents' initiation and continuity of treatment for their child. , 2009, Journal of child and adolescent psychopharmacology.

[30]  J. Parr,et al.  Current practice in the management of Attention Deficit Disorder with Hyperactivity (ADHD). , 2003, Child: care, health and development.

[31]  Andrew Lloyd,et al.  Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[32]  R. Schachar,et al.  Stimulant treatment over five years: adherence, effectiveness, and adverse effects. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[33]  R. Bussing,et al.  Knowledge and information about ADHD: evidence of cultural differences among African-American and white parents. , 1998, Social science & medicine.

[34]  M. Dulcan,et al.  Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[35]  P. S. Jensen ARE STIMULANTS OVERPRESCRIBED , 2000 .

[36]  S. dosReis,et al.  Parental attitudes and involvement in psychopharmacological treatment for ADHD: A conceptual model , 2008, International review of psychiatry.

[37]  B. Vitiello,et al.  Prevalence of severe ADHD: an epidemiological study in the Italian regions of Tuscany and Latium , 2014, Epidemiology and Psychiatric Sciences.

[38]  Stephen P. Hinshaw,et al.  A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. , 1999, Archives of general psychiatry.

[39]  J. Callahan,et al.  The impact of client treatment preferences on outcome: a meta-analysis. , 2009, Journal of clinical psychology.

[40]  Terry N Flynn,et al.  Using Best-Worst Scaling Choice Experiments to Measure Public Perceptions and Preferences for Healthcare Reform in Australia , 2010, The patient.

[41]  F. Gary,et al.  Exploring Help‐Seeking for ADHD Symptoms: A Mixed‐Methods Approach , 2005, Harvard review of psychiatry.

[42]  C. Hoven,et al.  Are stimulants overprescribed? Treatment of ADHD in four U.S. communities. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[43]  J. Swanson,et al.  Stimulant-related reductions of growth rates in the PATS. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

[44]  J. Louviere,et al.  Determining the Appropriate Response to Evidence of Public Concern: The Case of Food Safety , 1992 .

[45]  A. Charach,et al.  Stigmatizing experiences of parents of children with a new diagnosis of ADHD. , 2010, Psychiatric services.

[46]  J. Baio,et al.  Mental health surveillance among children--United States, 2005-2011. , 2013, MMWR supplements.

[47]  J. Swanson,et al.  Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. , 1999, Archives of general psychiatry.

[48]  F. Gary,et al.  Barriers to detection, help-seeking, and service use for children with ADHD symptoms , 2003, The Journal of Behavioral Health Services & Research.

[49]  Joanna Coast,et al.  Estimating preferences for a dermatology consultation using Best-Worst Scaling: Comparison of various methods of analysis , 2008, BMC medical research methodology.